The retrospective study of 77 patients followed the device implantation to five years past surgery. Researchers found 100 percent of patients experienced a reduction in intervertebral pain immediately and one year later.
More Articles on Devices:
46 Spine & Orthopedic Devices Receive FDA 510(k) Clearance in October
Lawnwood Regional Medical Center Purchases Mazor Robotics’ Renaissance Spine System
Titan Spine Celebrates 18k Implantations of Interbody Fusion Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
